Literature DB >> 1330614

Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.

N Mallard1, R Marshall, A Sithers, B Spriggs.   

Abstract

The effects of the putative P2 purinoceptor antagonist suramin on contractile responses of the rat isolated vas deferens to electrical field stimulation and exogenously applied drugs (alpha,beta-methylene ATP and noradrenaline) were investigated. Suramin was devoid of agonist activity in the rat vas deferens. The response of the vas deferens to single pulse field stimulation was characteristically biphasic with a large first component peaking between 260-300 ms after the stimulus followed by a second smaller component peaking at about 650 ms post-stimulus. Suramin (100 nM-1 mM) selectively impaired the first, purinergic phase of the response to single pulse field stimulation but was without effect on the second, noradrenergic component. The response of the vas deferens to trains of electrical field stimuli (10 Hz for 10 s) was also biphasic. Suramin (1 microM-1 mM) reduced the first (less than 1 s) phase of the response by 30%, the second (greater than 5 s) plateau phase by 50% and inhibited the intermediate (2-4 s) phase by 80%. Dose-contact periods of 20 or 30 min respectively were sufficient to achieve equilibration of the inhibitory effects of suramin against the responses to single pulse field stimulation or trains of pulses. Following 30 min incubation with 1 mM suramin, the remaining first and second phase components of the response to trains of pulses were impaired and subsequently abolished by the alpha 1-adrenoceptor antagonist WB4101 establishing their noradrenergic origin. Suramin (300 microM) abolished responses of the vas deferens to alpha,beta-methylene ATP but was without effect on those to noradrenaline. Suramin (30 microM) induced a rightward shift in the concentration-response relationship to alpha,beta-methylene ATP that was associated with a significant 40% increase in the maximum response, but did not modify responses to noradrenaline. The inhibitory effects of suramin (3-300 microM) on responses of the vas deferens to approximate EC50 concentrations of alpha,beta-methylene ATP were reversible on repeated washout for 40-60 min. These results reveal suramin to be a useful pharmacological tool for the study of purinergic neurotransmission in rodent vasa deferentia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330614     DOI: 10.1016/0014-2999(92)90004-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.

Authors:  M Guitart; J Giraldo; E Goñalons; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 2.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 3.  Physiology of the vas deferens.

Authors:  W D Steers
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Failure of tyramine to release neuronal ATP as a cotransmitter of noradrenaline in the guinea-pig vas deferens.

Authors:  B Driessen; J Gonçalves; B Szabo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Release of ATP in rat vas deferens: origin and role of calcium.

Authors:  A K Kurz; R Bültmann; B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.

Authors:  D J Trezise; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells.

Authors:  Yan Sun; Susan Keay; Todd J Lehrfeld; Toby C Chai
Journal:  Urology       Date:  2009-07-22       Impact factor: 2.649

9.  Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors.

Authors:  R Bültmann; B Szabo; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

10.  Electrically-evoked release of taurine in the rat vas deferens: evidence for a purinoceptor-mediated effect.

Authors:  G Queiroz; J Gonçalves; F Carvalho; P Vale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.